Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Coronary Slow Flow or No-Reflow During Elective Percutaneous Coronary Intervention in Patients With Acute ST-segment Elevation Myocardial Infarction

NCT03406832 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Zhengzhou University as lead sponsor.

NCT NCT03406832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03406832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Coronary Slow Flow or No-Reflow During Elective Percutaneous Coronary Intervention in Patients With Acute ST-segment Elevation Myocardial Infarction
Lead sponsor
The First Affiliated Hospital of Zhengzhou University
Phase
Not applicable
Overall status
Unknown status
Start date
January 8, 2018
Completion date
December 31, 2019
Enrollment
1,000 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

elective percutaneous coronary intervention, st segment elevation myocardial infarction